← Back to headlines
Ambu Shares Plunge 17% After Second Consecutive Sales Forecast Downgrade
Ambu stock fell sharply following the medical device manufacturer's second consecutive downward revision of its annual sales guidance, triggering significant investor concern over near-term demand and prompting analysts to reassess market positioning.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
